Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery

Circulating tumour DNA (ctDNA) has the potential to be a specific biomarker for the monitoring of tumours in patients with colorectal cancer (CRC). Here, our aim was to develop a personalised surveillance strategy to monitor the clinical course of CRC after surgery. We developed patient-specific ctD...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Sarah B., Chua, Clarinda, Ng, Matthew, Gan, Anna, Poon, Polly SY, Teo, Melissa, Fu, Cherylin, Leow, Wei Qiang, Lim, Kiat Hon, Chung, Alexander, Koo, Si-Lin, Choo, Su Pin, Ho, Danliang, Rozen, Steve, Tan, Patrick, Wong, Mark, Burkholder, William F., Tan, Iain Beehuat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244357/
https://www.ncbi.nlm.nih.gov/pubmed/28102343
http://dx.doi.org/10.1038/srep40737

Ejemplares similares

Ejemplares similares